TH1501000960A - Antibodies and vaccines for the treatment of ROR1 cancer and inhibit metastasis. - Google Patents
Antibodies and vaccines for the treatment of ROR1 cancer and inhibit metastasis.Info
- Publication number
- TH1501000960A TH1501000960A TH1501000960A TH1501000960A TH1501000960A TH 1501000960 A TH1501000960 A TH 1501000960A TH 1501000960 A TH1501000960 A TH 1501000960A TH 1501000960 A TH1501000960 A TH 1501000960A TH 1501000960 A TH1501000960 A TH 1501000960A
- Authority
- TH
- Thailand
- Prior art keywords
- ror1
- vaccines
- antibodies
- treatment
- inhibit metastasis
- Prior art date
Links
- 102100017729 ROR1 Human genes 0.000 title claims abstract 7
- 101710036428 ROR1 Proteins 0.000 title claims abstract 7
- 101700058902 RORA Proteins 0.000 title claims abstract 7
- 102000004965 antibodies Human genes 0.000 title claims abstract 3
- 108090001123 antibodies Proteins 0.000 title claims abstract 3
- 229960005486 vaccines Drugs 0.000 title claims abstract 3
- 206010027476 Metastasis Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 claims abstract 2
- 102000038129 antigens Human genes 0.000 claims abstract 2
- 108091007172 antigens Proteins 0.000 claims abstract 2
- 239000005426 pharmaceutical component Substances 0.000 claims abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract 2
- 230000000644 propagated Effects 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
Abstract
คำขอใหม่ปรับปรุง 29/08/2016 การประดิษฐ์นี้เกี่ยวข้องกับองค์ประกอบทางเภสัชกรรม และวิธีการในการยับยั้งการ แพร่กระจายโดยใช้แอนติบอดีที่ต้าน ROR1 หรือชิ้นส่วนที่เข้าจับกับแอนติเจน, เปปไทด์ที่เข้า จับกับ ROR1 และวัคซีนของ ROR1 New request updated 29/08/2016 This invention relates to pharmaceutical components. And methods to stop the It was propagated using ROR1-resistant antibodies or antigen-binding fragments, ROR1-bound peptides, and ROR1 vaccines.
Claims (1)
Publications (1)
Publication Number | Publication Date |
---|---|
TH1501000960A true TH1501000960A (en) | 2019-11-18 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU20170169A7 (en) | FACTOR ANTIBODIES XI | |
CY1122804T1 (en) | MONOCLONAL ANTIBODIES AGAINST HUMAN B-CELL MATURATION ANTIGEN (BCMA) | |
UA117364C2 (en) | Amatoxin derivatives | |
PH12017500890A1 (en) | Antibody drug conjugates | |
CU20160101A7 (en) | IMMUNOGLOBULINA WITH FAB IN TANDEM | |
BR112015021134A2 (en) | drug and antibody conjugates | |
WO2014160160A3 (en) | Antibody drug conjugates and corresponding antibodies | |
PH12017500002A1 (en) | Anti-cdh6 antibody drug conjugates | |
EA201890530A1 (en) | CONJUGATES ANTIBODIES TO DLL3 AND MEDICINES AND METHODS OF THEIR USE | |
WO2015091853A3 (en) | Human anti-cd40 human antibodies | |
WO2014163714A3 (en) | Antibody drug conjugates | |
UA115439C2 (en) | Humanized antibodies that recognize alpha-synuclein | |
PH12016502061A1 (en) | Novel antii-rnf43 antibodies and methods of use | |
EA202091315A3 (en) | HUMAN ANTIBODIES BINDING G-PROTEIN RSV | |
UA113623C2 (en) | TISSUE FACTOR FACTOR (TFPI) MONOCLONAL ANTIBODY AGAINST TISSUE FACTOR INHIBITOR | |
BR112016014731A2 (en) | ANTI-BAFF ANTIBODIES | |
CO2018012497A2 (en) | Interferon beta antibodies and uses thereof | |
EA201591898A1 (en) | ANTIBODIES DIRECTED TO M-CSF | |
GT201300058A (en) | ANTI-VEGFR-3 ANTIBODY COMPOSITIONS | |
TH1501000960A (en) | Antibodies and vaccines for the treatment of ROR1 cancer and inhibit metastasis. | |
TH1701000860A (en) | Antibody Antibody-TIGIT | |
TH181126A (en) | PD-1 Antibody, a fragment that binds to that antigen of that antibody. And the medical use of antibodies | |
TH180920A (en) | Antibodies bind to FCRN for the treatment of autoimmune diseases. | |
TH180776A (en) | "Method for upregulating antigen expression" | |
TH133365A (en) | Antine-N3pGlu, Amyloid Beta-Peptide Antibody and Its Uses |